Organogenesis Holdings (ORGO) Change in Receivables (2016 - 2026)

Organogenesis Holdings' Change in Receivables history runs 11 years deep, the most recent figure standing at -$104.5 million for Q1 2026.

• In Q1 2026, Change in Receivables fell 1743.72% year-over-year to -$104.5 million; the TTM figure through Mar 2026 stood at $17.0 million (up 54.05% YoY), while the FY2025 annual figure was $115.8 million, up 264.16% from the prior year.
• Change in Receivables was -$104.5 million for Q1 2026 at Organogenesis Holdings, down from $51.5 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $51.5 million in Q4 2025 to a low of -$104.5 million in Q1 2026.
• Historically, Change in Receivables has averaged $2.7 million across 5 years, with a median of $3.4 million in 2023.
• The sharpest annual moves came in 2025 and 2026: Change in Receivables soared 1799.8% in 2025, then tumbled 1743.72% in 2026.
• A 5-year view of Change in Receivables shows it stood at -$2.7 million in 2022, then tumbled by 166.42% to -$7.3 million in 2023, then surged by 220.6% to $8.8 million in 2024, then surged by 484.71% to $51.5 million in 2025, then slumped by 303.0% to -$104.5 million in 2026.
• The last three Change in Receivables figures came in at -$104.5 million (Q1 2026), $51.5 million (Q4 2025), and $50.7 million (Q3 2025), per Business Quant data.